Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Markman

Showing results (91-100 of 545) with videos related to

Pageof 55
Sort By:
The Western Journal of Medicine|March 1, 1985
Intracavitary chemotherapy for malignant disease confined to body cavitiesM Markman
Cleveland Clinic Journal of Medicine|January 1, 1997
When and how to use serum tumor markers in clinical practiceM Markman
Cancer Investigation|January 1, 1996
Should cost be considered in the overall evaluation of phase II clinical trials of new antineoplastic therapies?M Markman
Cancer Treatment and Research|January 1, 1996
Intraperitoneal taxolM Markman
Seminars in Oncology|April 1, 1994
Intraperitoneal cisplatin and carboplatin in the management of ovarian cancerM Markman
Seminars in Oncology|August 1, 1994
Introduction: treatment of malignancies poorly responsive to currently available antineoplastic therapyM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Twenty-fifth meeting of the Society of Gynecologic Oncologists. Orlando, Florida, February 1994M Markman
Cleveland Clinic Journal of Medicine|January 1, 1994
Ovarian cancer update: management challenges and advancesM Markman
Gynecologic Oncology|October 1, 1993
Salvage therapy in ovarian cancer: is there a role for intraperitoneal drug delivery?M Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Report from the 29th annual meeting of the American Society of Clinical Oncology, 16-18 May 1993, Orlando, FloridaM Markman
Pageof 55

Showing results (91-100 of 545) with videos related to

Sort By:
Pageof 55
The Western Journal of Medicine|March 1, 1985
Intracavitary chemotherapy for malignant disease confined to body cavitiesM Markman
Cleveland Clinic Journal of Medicine|January 1, 1997
When and how to use serum tumor markers in clinical practiceM Markman
Cancer Investigation|January 1, 1996
Should cost be considered in the overall evaluation of phase II clinical trials of new antineoplastic therapies?M Markman
Cancer Treatment and Research|January 1, 1996
Intraperitoneal taxolM Markman
Seminars in Oncology|April 1, 1994
Intraperitoneal cisplatin and carboplatin in the management of ovarian cancerM Markman
Seminars in Oncology|August 1, 1994
Introduction: treatment of malignancies poorly responsive to currently available antineoplastic therapyM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Twenty-fifth meeting of the Society of Gynecologic Oncologists. Orlando, Florida, February 1994M Markman
Cleveland Clinic Journal of Medicine|January 1, 1994
Ovarian cancer update: management challenges and advancesM Markman
Gynecologic Oncology|October 1, 1993
Salvage therapy in ovarian cancer: is there a role for intraperitoneal drug delivery?M Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Report from the 29th annual meeting of the American Society of Clinical Oncology, 16-18 May 1993, Orlando, FloridaM Markman
Pageof 55